23
Participants
Start Date
May 31, 2012
Primary Completion Date
March 31, 2015
Study Completion Date
July 31, 2015
Head and neck
"Eribulin mesylate is administered by IV infusion over 2-5 minutes on day 1 and 8 of a 21 day cycle 1.4mg/m2 and Cetuximab 400 mg/m2 cycle 1 week 1, then 250 mg/m2/weekly thereafter~Dose Level 1: 0.7 mg/m2 IV infusion days 1 and 8 of 21 day cycle Dose Level 2: 1.0 mg/m2 IV infusion days 1 and 8 of 21 day cycle Dose Level 3: 1.4 mg/m2 IV infusion days 1 and 8 of 21 day cycle"
Colon- Closed as of May 2014
"Eribulin Mesylate:~1.4 mg/m2 IV infusion days 1 and 8 of 21 day cycle"
Montefiore, The Bronx
Memorial Hospital, Pawtucket
Rhode Island Hospital, Providence
The Miriam Hospital, Providence
Fatima Memorial Hospital
OTHER
Montefiore Medical Center
OTHER
Rhode Island Hospital
OTHER
The Miriam Hospital
OTHER
howard safran
OTHER